IMMUNODEFICIENCY IN CANCER AND IMPORTANCE OF IMMUNE EVALUATION OF CANCER PATIENT

被引：43

作者：

HERSH, EM ^{[1
]}

MAVLIGIT, GM ^{[1
]}

GUTTERMAN, JU ^{[1
]}

机构：

[1] UNIV TEXAS MD ANDERSON HOSP & TUMOR INST,CTR SYST CANC,DEPT DEV THERAPEUTICS,HOUSTON,TX 77025

来源：

MEDICAL CLINICS OF NORTH AMERICA | 1976年 / 60卷 / 03期

关键词：

D O I：

10.1016/S0025-7125(16)31902-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：623 / 639

页数：17

共 85 条

[71]

SAVEL H, 1971, P SOC EXP BIOL MED, V137, P374, DOI 10.3181/00379727-137-35580

[72]

SCHEURLEN PG, 1971, LANCET, V2, P1265

[73] CUTANEOUS ANERGY AND HODGKINS DISEASE [J].

SCHIER, WW .

NEW ENGLAND JOURNAL OF MEDICINE, 1954, 250 (09) :353-361

[74] CURRENT CONCEPTS - LOOK AT IMMUNOLOGICAL SURVEILLANCE [J].

SCHWARTZ, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (04) :181-184

[75]

SELYE H, 1950, PHYSIOLOGY PATHOLOGY

[76] EXPRESSION OF CELL-SURFACE MARKERS ON T AND B LYMPHOCYTES AFTER LONG-TERM CHEMOTHERAPY OF ACUTE LEUKEMIA [J].

SEN, L ;

BORELLA, L .

CELLULAR IMMUNOLOGY, 1973, 9 (01) :84-95

[77]

STJERNSW.J, 1972, LANCET, V1, P1352

[78]

STUTMAN O, 1974, FED PROC, V33, P2028

[79] SERUM INHIBITORY FACTORS IN CANCER [J].

SUCIUFOCA, N ;

BUDA, JA ;

LOGERFO, P ;

MOULTON, A ;

WEBER, C ;

WHEELER, B ;

REEMTSMA, K .

ONCOLOGY, 1974, 29 (03) :219-226

[80]

TWOMEY PL, 1974, CANCER, V33, P435, DOI 10.1002/1097-0142(197402)33:2<435::AID-CNCR2820330219>3.0.CO

← 1 2 3 4 5 6 7 8 9 →